Prescription drug · ANDA
acetaZOLAMIDE NDC 50090-7536
Acetazolamide 250 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7536-0 | 50090753600 | 12 TABLET in 1 BOTTLE (50090-7536-0)Marketed from Apr 9, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- acetaZOLAMIDE
- Generic name (nonproprietary)
- acetazolamide
- Active ingredients
- Acetazolamide — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211069
- Marketing start
- Listing expires
- Other FDA classes
- Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
- Identifiers
- Product ID 50090-7536_0c0d69e8-f78e-4286-ad4a-77e3719e16acSPL ID 0c0d69e8-f78e-4286-ad4a-77e3719e16acSPL set ID b339843f-0324-4996-88a0-0619fd6f867bRxCUI 197304UNII O3FX965V0I
- Pharmacologic class
- Carbonic Anhydrase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090753600followed by a unit qualifier and the quantityPackage 50090-7536-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 211069
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| acetaZOLAMIDE | Acetazolamide 125 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3632 |
| acetaZOLAMIDE | Acetazolamide 125 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-149 |
| acetaZOLAMIDE | Acetazolamide 250 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-150 |
| acetaZOLAMIDE | Acetazolamide 125 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1238 |
| acetaZOLAMIDE | Acetazolamide 250 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1239 |
| acetaZOLAMIDE | Acetazolamide 125 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1827 |
| acetaZOLAMIDE | Acetazolamide 250 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1828 |